PPIST02380
Protein Information
| Protein_Chain | A |
|---|---|
| Protein_Sequence | DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG |
Peptide Information
| Peptide_Chain | B |
|---|---|
| Peptide_Sequence | DFEEIPEEYL |
| Peptide_Length | 10 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 1ZGV |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.20 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimization. |
|---|---|
| Release_Year | 2005 |
| PMID | 16137886 |
| DOI | 10.1016/j.bmcl.2005.07.022 |